中国神经再生研究(英文版) ›› 2022, Vol. 17 ›› Issue (2): 246-250.doi: 10.4103/1673-5374.317958

• 综述:退行性病与再生 • 上一篇    下一篇

“献祭”:自噬蛋白在神经炎症和神经变性中的非典型功能

  

  • 出版日期:2022-02-15 发布日期:2021-10-08

Dying by fire: noncanonical functions of autophagy proteins in neuroinflammation and neurodegeneration

Alexis D. Rickman1, #, Addison Hilyard2, #, Bradlee L. Heckmann2, 3, *   

  1. 1Department of Cell Biology, Microbiology & Molecular Biology University of South Florida, Tampa, FL, USA; 2USF Health Byrd Alzheimer’s Center and Neuroscience Institute, Morsani College of Medicine, Tampa, FL, USA; 3Department of Molecular Medicine, Morsani College of Medicine, Tampa, FL, USA
  • Online:2022-02-15 Published:2021-10-08
  • Contact: Bradlee L. Heckmann, PhD, bheckmann@usf.edu.
  • Supported by:
    This work was supported in part by the funding from the National Institute of Allergy and Infectious Disease and the National Cancer Institute under award numbers AI138492 and CA231423 to BLH. 

摘要: Neural Regen Res: LC3相关内吞作用如何减轻神经炎症和神经退行性变
    神经炎症和神经退行性变是包括阿尔茨海默病在内的神经退行性疾病发生和发展的关键因素。最近发现了一种利用自噬机制的成分将LC3靶向内质体的途径,称为LC3相关内吞作用(LANDO),并证明其可调节神经炎症。
来自美国南佛罗里达大学的Bradlee L. Heckmann团队重申了神经炎症对阿尔茨海默病疾病进程的重要性,神经炎症是疾病发生和发展的中心。神经炎症不仅在阿尔茨海默病中是一个有潜力的治疗靶点,而且在大量其他中枢神经系统退行性疾病中也是如此,包括亨廷顿病、帕金森病和肌萎缩侧索硬化症。特别是,神经炎症调节在肌萎缩侧索硬化症和帕金森病的治疗中具有很好的疗效。与常规自噬相比, LANDO有明显的调节作用,并且每个通路可能独立于其他通路发挥作用。随着年龄的增长,自噬机制和LANDO的组成部分持续下调,在阿尔茨海默病大脑中观察到的表达进一步降低。随着基因治疗的进步,将很快有能力在人类患者中靶向这些上游调节因子和相关通路,这不再是不可想象的。
    文章在《中国神经再生研究(英文版)》杂志2021年 2 月 2 期发表。

https://orcid.org/0000-0002-3271-7183 (Bradlee L. Heckmann) 

Abstract: Neuroinflammation and neurodegeneration are key components in the establishment and progression of neurodegenerative diseases including Alzheimer’s Disease (AD). Over the past decade increasing evidence is emerging for the use of components of the canonical autophagy machinery in pathways that are characterized by LC3 lipidation yet are distinct from traditional macro-autophagy. One such pathway that utilizes components of the autophagy machinery to target LC3 to endosomes, a process termed LC3-associated endocytosis (LANDO), has recently been identified and regulates neuroinflammation. Abrogation of LANDO in microglia cells results in a propensity for elevated neuroinflammatory cytokine production. Using the well-established 5xFAD model of AD to interrogate neuroinflammatory regulation, impairment of LANDO through deletion of a key upstream regulator Rubicon or other downstream autophagy components, exacerbated disease onset and severity, while deletion of microglial autophagy alone had no measurable effect. Mice presented with robust deposition of the neurotoxic AD protein β-amyloid (Aβ), microglial activation and inflammatory cytokine production, tau phosphorylation, and aggressive neurodegeneration culminating in severe memory impairment. LANDO-deficiency impaired recycling of receptors that recognize Aβ, including TLR4 and TREM2. LANDO-deficiency alone through deletion of the WD-domain of the autophagy protein ATG16L, revealed a role for LANDO in the spontaneous establishment of age-associated AD. LANDO-deficient mice aged to 2 years presented with advanced AD-like disease and pathology correlative to that observed in human AD patients. Together, these studies illustrate an important role for microglial LANDO in regulating CNS immune activation and protection against neurodegeneration. New evidence is emerging that demonstrates a putative linkage between pathways such as LANDO and cell death regulation via apoptosis and possibly necroptosis. Herein, we provide a review of the use of the autophagy machinery in non-canonical mechanisms that alter immune regulation and could have significant impact in furthering our understanding of not only CNS diseases like AD, but likely beyond.  

Key words: aging, Alzheimer’s disease, autophagy, inflammation, LC3-associated endocytosis, microglia, neurodegeneration, neuroinflammation